Trial Profile
A pilot study to examine the feasibility and effect on tumor necrosis factor (TNF) inhibition on HIV disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 25 Oct 2016 Status changed from recruiting to completed.
- 28 Oct 2006 New trial record.